Literature DB >> 10529398

In vitro transcriptional and translational block of the bcl-2 gene operated by peptide nucleic acid.

L Mologni1, P E Nielsen, C Gambacorti-Passerini.   

Abstract

The antisense and antigene activity of peptide nucleic acid (PNA) targeted to the human B-cell lymphoma (bcl)-2 gene was evaluated in vitro. Several PNAs complementary to different sequences of bcl-2, including the start codon and the 5'-untranslated region (5'-UTR), were tested. One PNA directed against the AUG start codon and another recognizing the 5'-UTR were able to specifically reduce Bcl-2 protein synthesis in a cell-free system; however, only partial inhibition (80 and 54%, respectively) was obtained when they were used singularly. Complete translation block was obtained with the simultaneous presence of both PNAs. A triplex-forming bis-PNA was targeted to a homopurine sequence on the coding strand of the bcl-2 cDNA. In an in vitro transcription assay this PNA specifically inhibited the transcription of bcl-2 at concentrations as low as 300 nM, with the concomitant appearance of a truncated 200-base-long product. These results demonstrate the ability of PNA to selectively modulate both translation and transcription of bcl-2 in vitro and suggest its potential use as an antisense and an antigene agent in order to downregulate bcl-2 expression in tumors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529398     DOI: 10.1006/bbrc.1999.1548

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Destabilization of tRNA3(Lys) from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog.

Authors:  N Kaushik; T T Talele; R Monel; P Palumbo; V N Pandey
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

2.  Fully modified 2' MOE oligonucleotides redirect polyadenylation.

Authors:  T A Vickers; J R Wyatt; T Burckin; C F Bennett; S M Freier
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

3.  Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.

Authors:  Raman Bahal; Nicole Ali McNeer; Danith H Ly; W Mark Saltzman; Peter M Glazer
Journal:  Artif DNA PNA XNA       Date:  2013 Apr-Jun

4.  Correction of a splice-site mutation in the beta-globin gene stimulated by triplex-forming peptide nucleic acids.

Authors:  Joanna Y Chin; Jean Y Kuan; Pallavi S Lonkar; Diane S Krause; Michael M Seidman; Kenneth R Peterson; Peter E Nielsen; Ryszard Kole; Peter M Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

Review 5.  Hematologic malignancies: newer strategies to counter the BCL-2 protein.

Authors:  Abdul Shukkur Ebrahim; Hussam Sabbagh; Allison Liddane; Ali Raufi; Mustapha Kandouz; Ayad Al-Katib
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-04       Impact factor: 4.553

Review 6.  microRNAs as Novel Therapeutics in Cancer.

Authors:  Giulia Romano; Mario Acunzo; Patrick Nana-Sinkam
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

Review 7.  The potential of antisense oligonucleotide therapies for inherited childhood lung diseases.

Authors:  Kelly M Martinovich; Nicole C Shaw; Anthony Kicic; André Schultz; Sue Fletcher; Steve D Wilton; Stephen M Stick
Journal:  Mol Cell Pediatr       Date:  2018-02-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.